Drug Type Autologous CAR-T |
Synonyms |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | KR | 22 Sep 2022 | |
Pancreatic Cancer | Preclinical | KR | 22 Sep 2022 | |
Stomach Cancer | Discovery | KR | 22 Sep 2022 |